AIAli Mbbs Imran

Ali Mbbs Imran

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ali Mbbs Imran has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mortality among U.S. adults with coexisting type 2 diabetes mellitus and malignant neoplasms: A nationwide observational study (1999–2024)

    by Muhammad Husnain Ahmad, Masab Ali, Muhammad Hassan, Muhammad Abdullah, Moiz Ul Haq Hashmi, Amina Jamil, Taha Mehmood, Abdullah Zaheer, Ahmad Zia, Muhammad Umar Shahid, et al.

    Type 2 diabetes mellitus (T2DM) and malignant neoplasms are among the most prevalent chronic diseases worldwide. When coexisting, they substantially increase morbidity and mortality. However, national trends in mortality among patients with coexisting T2DM and malignant neoplasms in the United States remain underexplored. We analyzed U.S. death certificates from the CDC WONDER database for individuals aged ≥ 25 years who died between 1999 and 2024 with both T2DM and malignant neoplasms listed anywhere on the death certificate (underlying or contributing causes). Age-adjusted mortality rates (AAMRs) and annual percent change (APC) were calculated by year, sex, age group, race/ethnicity, geographic region, and urbanization status. From 1999 to 2024, 357,910 U.S. deaths occurred among individuals in whom both Type 2 Diabetes Mellitus and Malignant Neoplasms were listed on the death certificate. The AAMR rose from 6.37 to 17.2 per 100,000, with an overall APC of + 3.84%. Men exhibited higher mortality than women. Older adults bore the greatest burden, though middle-aged adults also showed a sharp proportional rise. Hispanic and Asian populations experienced the steepest increases. The West region showed the most pronounced growth. State-level variation exceeded fivefold, with Nebraska reporting the highest AAMR and Nevada the lowest. nonmetropolitan areas maintained higher mortality throughout, but metropolitan areas demonstrated a steeper rise, narrowing the rural–urban gap. Mortality among individuals with coexisting T2DM and malignant neoplasms has risen substantially in the U.S., with disproportionate increases among men, minority populations, and urban residents. These findings highlight the urgent need for integrated strategies addressing diabetes control, cancer prevention, and health equity across demographic and geographic subgroups.

  • Open Access

    Emerging trends and disparities in mortality due to coexisting atrial fibrillation and sepsis: A US nationwide observational study (1999–2023)

    by Masab Mbbs Ali, Rehan Mbbs Naseer Ahmad, Muhammad Mbbs Hassan, Moiz Ul Haq Mbbs Hashmi, Madiha Kiyani, Ahmad Mbbs Zia, Jawaria Mbbs Firdous, Muhammad Husnain Mbbs Ahmad, Ali Mbbs Imran, Amina Mbbs Jamil, et al.

    Sepsis patients are highly susceptible to atrial fibrillation (AF) and atrial flutter due to the proinflammatory and adrenergic milieu, which precipitates arrhythmogenesis, especially in vulnerable individuals. Understanding mortality trends and disparities in this population is essential for targeted interventions. We analyzed US death certificates from the Center of Disease Control Wide-Ranging Online Data for Epidemiologic Research database for individuals aged ≥25 years who died between 1999 and 2023 with both sepsis and AF listed as causes. We calculated age-adjusted mortality rates (AAMRs), which measure changes in death rates over time while accounting for differences in age distribution, and annual percent change to evaluate yearly trends in these rates across demographic groups stratified by year, sex, age group, race/ethnicity, geographic region, and urbanization status. A total of 2,40,222 deaths involved both AF/atrial flutter and sepsis. The overall AAMR increased from 2.0 per 1,00,000 in 1999 to a peak of 7.9 in 2021 (annual percent change +5.6% through 2018, accelerating to +12.6% through 2021), with a slight decline to 7.1 by 2023. Mortality was consistently higher in men than women, older adults, residents of nonmetropolitan areas, and the US South. By race/ethnicity, non-Hispanic White and Black individuals had the highest AAMRs, followed by American Indian/Alaska Native, Hispanic, and Asian/Pacific Islander populations. Deaths involving AF and sepsis have risen substantially over the past 4 decades, with sharp increases in recent years and persistent disparities by age, sex, race/ethnicity, and geography. These findings underscore the need for integrated arrhythmia–sepsis management strategies, enhanced access to critical care in underserved regions, and equity-focused public health interventions to mitigate mortality.